MYH7 Inhibitors

MYH7, also known as myosin heavy chain 7, is a protein primarily found in cardiac muscle fibers. It is a key component of the sarcomere, the basic contractile unit of muscle cells, where it functions as a molecular motor responsible for generating force and movement during cardiac contraction. MYH7 is specifically involved in the conversion of chemical energy into mechanical work, a process essential for the contraction and relaxation of the heart muscle. Through its ATPase activity, MYH7 hydrolyzes ATP to ADP and inorganic phosphate, releasing energy that is utilized to drive the movement of actin and myosin filaments relative to each other, resulting in muscle contraction. This process, known as the sliding filament theory, underlies the fundamental mechanism of muscle contraction in the heart.

Inhibition of MYH7 activity can occur through various mechanisms, ultimately leading to impaired muscle contraction and relaxation. One common mechanism involves the binding of inhibitory molecules to specific sites on MYH7, interfering with its ATPase activity and disrupting the normal cycle of muscle contraction. Additionally, alterations in the phosphorylation status of MYH7 or its regulatory proteins can modulate its activity and lead to inhibition. For example, phosphorylation of regulatory proteins such as myosin binding protein-C (MyBP-C) can alter the interaction between MYH7 and actin, thereby inhibiting muscle contraction. Furthermore, changes in intracellular calcium levels, which play a crucial role in regulating muscle contraction, can indirectly affect MYH7 activity and contribute to inhibition. Overall, inhibition of MYH7 function results in impaired contractile performance of cardiac muscle, which can have significant implications for cardiac function and overall cardiovascular health.